Mystic Asset Management Inc. Has $336,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Mystic Asset Management Inc. grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 20.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 660 shares of the healthcare conglomerate’s stock after buying an additional 113 shares during the quarter. Mystic Asset Management Inc.’s holdings in UnitedHealth Group were worth $336,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Signature Resources Capital Management LLC raised its holdings in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares in the last quarter. Saxony Capital Management LLC raised its holdings in UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after buying an additional 18 shares in the last quarter. GoalVest Advisory LLC boosted its stake in shares of UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after acquiring an additional 18 shares in the last quarter. Fiduciary Group LLC lifted its holdings in UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after purchasing an additional 18 shares during the last quarter. Finally, Continuum Advisory LLC grew its holdings in UnitedHealth Group by 0.6% during the second quarter. Continuum Advisory LLC now owns 3,410 shares of the healthcare conglomerate’s stock valued at $1,737,000 after purchasing an additional 19 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research analyst reports. TD Cowen raised their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Barclays lifted their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Morgan Stanley raised their target price on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, September 10th. Finally, Wells Fargo & Company upped their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

Read Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Price Performance

Shares of UNH stock opened at $594.32 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The stock’s fifty day simple moving average is $569.08 and its 200 day simple moving average is $517.57. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The firm has a market cap of $548.81 billion, a price-to-earnings ratio of 36.33, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the company posted $6.14 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend is Monday, September 16th. UnitedHealth Group’s payout ratio is presently 51.34%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.